After a federal judge delivered a monumental blow to the NCAA in a high-profile antitrust lawsuit, the case is still far from over.
US District Judge Claudia Wilken ruled Friday that the NCAA must implement a plan to compensate its student athletes for the NCAA’s business endeavors involving the names and likeness of the athletes. The class action, filed by former UCLA basketball star Ed O’Bannon, was seen as a potentially crippling case to the NCAA’s business model and now threatens to turn the world of college sports upside down.
But with Judge Wilken’s ruling, the case will likely drag on for the foreseeable future.
The NCAA’s president Mark Emmert announced Sunday that the group will appeal Friday’s ruling. The announcement was the first public statement made by the NCAA since the decision.
And with a lengthy appeals process ahead, the case will expand even further as collegiate athletes look for ways to broaden the implications of Judge Wilken’s ruling.
The plaintiffs’ lead attorney Michael Hausfeld told reporters Saturday that his team is now looking for possible other legal claims that could piggyback on Friday’s decision. Lawyers are now eyeing possible new challenges to be made on behalf of athletes other than collegiate football and men’s basketball, the sports covered by the decision.
Hausfeld is also reportedly considering ways to expand the ongoing case before the National Labor Relations Board that is hearing a dispute over Northwestern University football players’ efforts to unionize, say reports.
Full content: USA Today
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas